PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ALGN vs. WST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ALGN and WST is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

ALGN vs. WST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Align Technology, Inc. (ALGN) and West Pharmaceutical Services, Inc. (WST). The values are adjusted to include any dividend payments, if applicable.

1,000.00%2,000.00%3,000.00%4,000.00%5,000.00%6,000.00%7,000.00%JulyAugustSeptemberOctoberNovemberDecember
1,119.30%
7,185.60%
ALGN
WST

Key characteristics

Sharpe Ratio

ALGN:

-0.52

WST:

-0.13

Sortino Ratio

ALGN:

-0.54

WST:

0.09

Omega Ratio

ALGN:

0.94

WST:

1.01

Calmar Ratio

ALGN:

-0.27

WST:

-0.12

Martin Ratio

ALGN:

-0.85

WST:

-0.25

Ulcer Index

ALGN:

23.01%

WST:

19.57%

Daily Std Dev

ALGN:

37.33%

WST:

38.73%

Max Drawdown

ALGN:

-92.80%

WST:

-55.52%

Current Drawdown

ALGN:

-71.08%

WST:

-29.19%

Fundamentals

Market Cap

ALGN:

$17.08B

WST:

$24.21B

EPS

ALGN:

$5.87

WST:

$6.75

PE Ratio

ALGN:

38.98

WST:

49.52

PEG Ratio

ALGN:

1.35

WST:

6.24

Total Revenue (TTM)

ALGN:

$3.96B

WST:

$2.88B

Gross Profit (TTM)

ALGN:

$2.79B

WST:

$1.00B

EBITDA (TTM)

ALGN:

$811.39M

WST:

$743.90M

Returns By Period

In the year-to-date period, ALGN achieves a -22.97% return, which is significantly lower than WST's -5.66% return. Over the past 10 years, ALGN has underperformed WST with an annualized return of 14.05%, while WST has yielded a comparatively higher 20.49% annualized return.


ALGN

YTD

-22.97%

1M

-5.72%

6M

-12.85%

1Y

-23.00%

5Y*

-5.02%

10Y*

14.05%

WST

YTD

-5.66%

1M

3.28%

6M

-0.28%

1Y

-6.41%

5Y*

17.32%

10Y*

20.49%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALGN vs. WST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Align Technology, Inc. (ALGN) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ALGN, currently valued at -0.52, compared to the broader market-4.00-2.000.002.00-0.52-0.13
The chart of Sortino ratio for ALGN, currently valued at -0.54, compared to the broader market-4.00-2.000.002.004.00-0.540.09
The chart of Omega ratio for ALGN, currently valued at 0.94, compared to the broader market0.501.001.502.000.941.01
The chart of Calmar ratio for ALGN, currently valued at -0.27, compared to the broader market0.002.004.006.00-0.27-0.12
The chart of Martin ratio for ALGN, currently valued at -0.85, compared to the broader market-5.000.005.0010.0015.0020.0025.00-0.85-0.25
ALGN
WST

The current ALGN Sharpe Ratio is -0.52, which is lower than the WST Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of ALGN and WST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50JulyAugustSeptemberOctoberNovemberDecember
-0.52
-0.13
ALGN
WST

Dividends

ALGN vs. WST - Dividend Comparison

ALGN has not paid dividends to shareholders, while WST's dividend yield for the trailing twelve months is around 0.24%.


TTM20232022202120202019201820172016201520142013
ALGN
Align Technology, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
WST
West Pharmaceutical Services, Inc.
0.24%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%0.77%0.78%

Drawdowns

ALGN vs. WST - Drawdown Comparison

The maximum ALGN drawdown since its inception was -92.80%, which is greater than WST's maximum drawdown of -55.52%. Use the drawdown chart below to compare losses from any high point for ALGN and WST. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%JulyAugustSeptemberOctoberNovemberDecember
-71.08%
-29.19%
ALGN
WST

Volatility

ALGN vs. WST - Volatility Comparison

Align Technology, Inc. (ALGN) has a higher volatility of 12.87% compared to West Pharmaceutical Services, Inc. (WST) at 6.80%. This indicates that ALGN's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
12.87%
6.80%
ALGN
WST

Financials

ALGN vs. WST - Financials Comparison

This section allows you to compare key financial metrics between Align Technology, Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab